IL1B and ischemic stroke: As immunosuppression with T lymphocyte depletion in the systemic circulation is an intrinsic component of the clinical syndrome during the subacute phase after ischemic stroke [94], a potential concern of targeting IL-1β and the innate immune system is an increased risk of infection due to further suppressing the immune system systemically.